173 related articles for article (PubMed ID: 24664099)
1. Group I PAK inhibitor IPA-3 induces cell death and affects cell adhesivity to fibronectin in human hematopoietic cells.
Kuželová K; Grebeňová D; Holoubek A; Röselová P; Obr A
PLoS One; 2014; 9(3):e92560. PubMed ID: 24664099
[TBL] [Abstract][Full Text] [Related]
2. Effect of P21-activated kinase 1 (PAK-1) inhibition on cancer cell growth, migration, and invasion.
Najahi-Missaoui W; Quach ND; Jenkins A; Dabke I; Somanath PR; Cummings BS
Pharmacol Res Perspect; 2019 Oct; 7(5):e00518. PubMed ID: 31516713
[TBL] [Abstract][Full Text] [Related]
3. An allosteric kinase inhibitor binds the p21-activated kinase autoregulatory domain covalently.
Viaud J; Peterson JR
Mol Cancer Ther; 2009 Sep; 8(9):2559-65. PubMed ID: 19723886
[TBL] [Abstract][Full Text] [Related]
4. Targeting Phosphorylation of p21-activated Kinase 1 at Thr423 Induces Cell Cycle Arrest and Apoptosis in Cutaneous T-cell Lymphoma Cells.
Wang Y; Li W; Zhang Q; Gu X; He X; Men Y; Zhang C
Acta Derm Venereol; 2019 Oct; 99(11):1022-1028. PubMed ID: 31304555
[TBL] [Abstract][Full Text] [Related]
5. An isoform-selective, small-molecule inhibitor targets the autoregulatory mechanism of p21-activated kinase.
Deacon SW; Beeser A; Fukui JA; Rennefahrt UE; Myers C; Chernoff J; Peterson JR
Chem Biol; 2008 Apr; 15(4):322-31. PubMed ID: 18420139
[TBL] [Abstract][Full Text] [Related]
6. Group I p21-activated kinases in leukemia cell adhesion to fibronectin.
Kuželová K; Obr A; Röselová P; Grebeňová D; Otevřelová P; Brodská B; Holoubek A
Cell Adh Migr; 2021 Dec; 15(1):18-36. PubMed ID: 33464167
[TBL] [Abstract][Full Text] [Related]
7. Suberoylanilide hydroxamic acid (SAHA) at subtoxic concentrations increases the adhesivity of human leukemic cells to fibronectin.
Kuzelová K; Pluskalová M; Brodská B; Otevrelová P; Elknerová K; Grebenová D; Hrkal Z
J Cell Biochem; 2010 Jan; 109(1):184-95. PubMed ID: 19911379
[TBL] [Abstract][Full Text] [Related]
8. Liposomes Targeting P21 Activated Kinase-1 (PAK-1) and Selective for Secretory Phospholipase A
Najahi-Missaoui W; Quach ND; Somanath PR; Cummings BS
Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33321758
[TBL] [Abstract][Full Text] [Related]
9. Changes in cell adhesivity and cytoskeleton-related proteins during imatinib-induced apoptosis of leukemic JURL-MK1 cells.
Kuželová K; Pluskalová M; Grebeňová D; Pavlásková K; Halada P; Hrkal Z
J Cell Biochem; 2010 Dec; 111(6):1413-25. PubMed ID: 20830748
[TBL] [Abstract][Full Text] [Related]
10. Group I p21-activated kinases (PAKs) promote tumor cell proliferation and survival through the AKT1 and Raf-MAPK pathways.
Menges CW; Sementino E; Talarchek J; Xu J; Chernoff J; Peterson JR; Testa JR
Mol Cancer Res; 2012 Sep; 10(9):1178-88. PubMed ID: 22798428
[TBL] [Abstract][Full Text] [Related]
11. PAK kinase regulates Rac GTPase and is a potential target in human schwannomas.
Flaiz C; Chernoff J; Ammoun S; Peterson JR; Hanemann CO
Exp Neurol; 2009 Jul; 218(1):137-44. PubMed ID: 19409384
[TBL] [Abstract][Full Text] [Related]
12. P21-Activated Kinase Inhibitors FRAX486 and IPA3: Inhibition of Prostate Stromal Cell Growth and Effects on Smooth Muscle Contraction in the Human Prostate.
Wang Y; Gratzke C; Tamalunas A; Wiemer N; Ciotkowska A; Rutz B; Waidelich R; Strittmatter F; Liu C; Stief CG; Hennenberg M
PLoS One; 2016; 11(4):e0153312. PubMed ID: 27071060
[TBL] [Abstract][Full Text] [Related]
13. Targeting p21-activated kinase 1 inhibits growth and metastasis via Raf1/MEK1/ERK signaling in esophageal squamous cell carcinoma cells.
Chen L; Bi S; Hou J; Zhao Z; Wang C; Xie S
Cell Commun Signal; 2019 Apr; 17(1):31. PubMed ID: 30971268
[TBL] [Abstract][Full Text] [Related]
14. Proteins implicated in the increase of adhesivity induced by suberoylanilide hydroxamic acid in leukemic cells.
Grebeňová D; Röselová P; Pluskalová M; Halada P; Rösel D; Suttnar J; Brodská B; Otevřelová P; Kuželová K
J Proteomics; 2012 Dec; 77():406-22. PubMed ID: 23022583
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of p21-Activated Kinase 1 by IPA-3 Promotes Locomotor Recovery After Spinal Cord Injury in Mice.
Ji X; Zhang Y; Zhang L; Chen H; Peng Y; Tang P
Spine (Phila Pa 1976); 2016 Jun; 41(11):919-925. PubMed ID: 26863260
[TBL] [Abstract][Full Text] [Related]
16. PAK Kinase Inhibition Has Therapeutic Activity in Novel Preclinical Models of Adult T-Cell Leukemia/Lymphoma.
Chung EY; Mai Y; Shah UA; Wei Y; Ishida E; Kataoka K; Ren X; Pradhan K; Bartholdy B; Wei X; Zou Y; Zhang J; Ogawa S; Steidl U; Zang X; Verma A; Janakiram M; Ye BH
Clin Cancer Res; 2019 Jun; 25(12):3589-3601. PubMed ID: 30862694
[TBL] [Abstract][Full Text] [Related]
17. PAK1 overexpression promotes cell proliferation in cutaneous T cell lymphoma via suppression of PUMA and p21.
Wang Y; Gu X; Li W; Zhang Q; Zhang C
J Dermatol Sci; 2018 Apr; 90(1):60-67. PubMed ID: 29307600
[TBL] [Abstract][Full Text] [Related]
18. IPA-3 inhibits the growth of liver cancer cells by suppressing PAK1 and NF-κB activation.
Wong LL; Lam IP; Wong TY; Lai WL; Liu HF; Yeung LL; Ching YP
PLoS One; 2013; 8(7):e68843. PubMed ID: 23894351
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of p21-activated kinase 1 by IPA-3 attenuates secondary injury after traumatic brain injury in mice.
Ji X; Zhang W; Zhang L; Zhang L; Zhang Y; Tang P
Brain Res; 2014 Oct; 1585():13-22. PubMed ID: 25148711
[TBL] [Abstract][Full Text] [Related]
20. Real-time monitoring of hematopoietic cell interaction with fibronectin fragment: the effect of histone deacetylase inhibitors.
Obr A; Röselová P; Grebeňová D; Kuželová K
Cell Adh Migr; 2013; 7(3):275-82. PubMed ID: 23567296
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
